Syndax Pharmaceuticals, Inc. (SNDX) vs Taysha Gene Therapies, Inc. (TSHA)
- Syndax Pharmaceuticals, Inc. SNDX 12.90 −5.49%
- Taysha Gene Therapies, Inc. TSHA 3.62 −2.95%
Syndax Pharmaceuticals, Inc. and Taysha Gene Therapies, Inc. are both Biotechnology companies. Syndax Pharmaceuticals, Inc. and Taysha Gene Therapies, Inc. are of similar size ($1.2B and $1.2B). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 222.3% against 19.0%. Taysha Gene Therapies, Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (0.00% vs −247.9%). Across the 17 metrics below, Taysha Gene Therapies, Inc. leads on 11 and Syndax Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | SNDX | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.78% | 100.00% | 65.16% |
| Operating margin | (77.05%) | 0.00% | 0.00% |
| Net margin | (87.60%) | 0.00% | 0.00% |
| Free cash flow margin | (87.64%) | 0.00% | 0.00% |
| Return on equity | (255.93%) | (47.05%) | (56.36%) |
| Return on assets | (33.97%) | (37.23%) | (48.04%) |
| Return on invested capital | (247.93%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack